Introduction: A surgical strategy for optimizing breast cancer therapy Laura EssermanKirby I. Bland OriginalPaper Pages: 1S - 2S
Neoadjuvant chemotherapy for primary breast cancer: Lessons learned and opportunities to optimize therapy Laura Esserman OriginalPaper Pages: 3S - 8S
Importance of correlative science in advancing hormonal therapy and a new clinical paradigm for neoadjuvant therapy Matthew J. Ellis OriginalPaper Pages: 9S - 17S
Role of endocrine therapy in the neoadjuvant surgical setting J. Michael Dixon OriginalPaper Pages: 18S - 23S
The role of clinical trials in changing therapy for ductal carcinoma in situ William C. Wood OriginalPaper Pages: 24S - 27S
Applying the neoadjuvant paradigm to ductal carcinoma in situ Laura EssermanKaren SepuchaE. Shelley Hwang OriginalPaper Pages: 28S - 36S
Neoadjuvant hormonal therapy for ductal carcinoma in situ: Trial design and preliminary results E. Shelley HwangLaura Esserman OriginalPaper Pages: 37S - 43S